European Cleanroom Technology Market Overview, Share, Growth Drivers and Forecast by 2023

The European cleanroom technology market is forecasted to generate $1,701.8 million revenue by 2023. The market is mainly driven by increasing number of conferences, seminars, and events for cleanroom technology, growing infectious diseases, and increasing healthcare expenditure in the region.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/europe-cleanroom-technology-market/report-sample

The different types of products available in the European cleanroom technology market are cleanroom consumables and equipment. The market for cleanroom consumables is expected to observe faster growth, witnessing a CAGR of more than 7.0% during the forecast period. The growth is mainly driven by the increasing adoption of these products to maintain aseptic environment in various industries, such as pharmaceutical, biotechnology, and medical devices; hospitals; and research laboratories.

On the basis of construction, the European cleanroom technology market is categorized into standard, hardwall, softwall, and pass-through cleanrooms. Hardwall cleanrooms is expected to be the fastest growing category in this market, exhibiting a CAGR of more than 7.5% during the forecast period. This growth is mainly due to increasing research and development (R&D) of pharmaceuticals in the region, which involves the use of hardwall cleanrooms, specifically designed for research activities.

Browse report at: https://www.psmarketresearch.com/market-analysis/europe-cleanroom-technology-market

The cleanroom technology market in France is expected to witness notable growth during the forecast period. This can be attributed to the improving healthcare infrastructure, presence of market players offering cleanroom technology solutions, increasing prevalence of chronic diseases, and rising initiatives by healthcare organizations for the use of cleanroom consumables and equipment in the country.

Some of the players in the European cleanroom technology industry include M+W Group GmbH, Ardmac Ltd., Alpiq Holding Ltd., cleanroom.de GmbH, OCTANORM-Vertriebs-GmbH, MonMouth Scientific Ltd., Cleanroom Systems Belgium, Parteco Srl, Mach-Aire Ltd., E.I. du Pont de Nemours and Company, Kimberly-Clark Corporation, Taikisha Ltd., and Illinois Tool Works Inc.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Wound Closure Devices Market Analysis, Growth, Prospect, Trends and Forecast by 2023

The growing need for reducing surgical expenditure has led to increasing demand for products that are able to improve the therapeutic outcome, and decrease the hospital stay tenure, which is majorly responsible for driving the growth of the global wound closure device market. On the basis of type, the global wound closure device market is segmented into mechanical stapling device, ligating clips, wound closure strips and others.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/wound-closure-device-market/report-sample

The mechanical stapling device segment would witness strong growth in the coming years, due to the increased efficiency, such as precision, safety, and reduced recovery time. The growing occurrence of chronic wound has increased the demand for efficient and cost effective wound healing products. Lifestyle diseases are majorly responsible for causing chronic wounds, such as diabetic foot ulcer, venous leg ulcer, and pressure ulcer. The risk involved with improper wound healing has promoted the demand for combination dressing, which is a modern way of wound dressing. By using the wound closing devices, the edge of wound tissues are pulled together for fast and effective healing.

The conventional wound closure techniques involve using sutures, also known as stitches. However, the modern methods for wound closure include adhesives, staples, sutures, hemostats, and sealants. Sutures are also available in various types such as braided, absorbable, monofilament, and non-absorbable.  Monofilament sutures are commonly used in ophthalmic, neurological, and cardiovascular surgeries. The basic function of these devices is closure of wound, both externally and internally, and stop bleeding through hemostasis, which solidifies blood.  However, the increasing demand for minimally invasive surgeries is responsible for hampering the growth of the wound closure devices market. Since, minimal invasion refers to reduced usage of wound strips, sutures as well as mechanical wound closure devices; the minimally invasive surgeries reduces the size of incisions made, hence lowering the requirement of wound closure devices market.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=wound-closure-device-market

The geographical divisions of the global wound closure devices market include North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America dominates the global market, owing to the presence of consumer base for knee replacement surgeries, spinal fusions, aesthetic surgeries, and hip replacement surgeries. In Asia-Pacific, the countries of the region are incapable of managing the huge inflow of patients in hospitals, which is increasing the demand for advanced wound closure devices, to facilitate faster wound closure and early discharge of existing patients.

The factors influencing the growth of the Asia-Pacific wound closure device market include development of new diagnostic centre and hospitals, increasing healthcare expenditure, and continuously evolving healthcare infrastructure in developing countries, such as India, China and Japan.

Browse report at: https://www.psmarketresearch.com/market-analysis/wound-closure-device-market

The major companies operating in the global wound closure device market include BSN medical, Baxter International, Teleflex Medical, Abbott Vascular, NeatStitch Ltd., Derma Sciences, and Ethicon Inc. (Johnson & Johnson).

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Urinary Tract Infections Therapeutics Pipeline Review 2018

Urinary tract infection (UTI) refer to a common bacterial infection disease, that occurs in either a community or healthcare setting. Clinically, UTIs are categorized as uncomplicated and complicated. Uncomplicated UTIs typically occur in a healthy adult non-pregnant woman and have no structural or neurological urinary tract abnormalities; these infections are differentiated into cystitis and pyelonephritis.

Explore report sample at: https://www.psmarketresearch.com/market-analysis/utis-therapeutics-pipeline/report-sample

UTIs are caused by both gram-negative and gram-positive bacteria, as well as by certain fungi. Gram-negative rod Escherichia coli is the most common cause of UTIs in all settings and is transmitted by person-to-person direct contact and the fecal-oral route. The study analyzed that Urinary Tract Infections therapeutics pipeline comprises approximately 40 drug candidates in different stages of development.

It has been observed that a majority of the companies in the UTIs therapeutic pipeline are developing drug candidates by using advanced technologies and these drug candidates have further shown positive efficacy in the clinical stage of development. For instance, MULTIPHORE Drug Design platform developed by Talon Pharmaceuticals Inc., specifies the complexity of the disease in nature. The above-mentioned technology is designed to identify the drug that interacts with multiple disease target through careful incorporation of multiple pharmacophores into a single molecule or through unique combination of different mechanisms of action implicated in the disease state.

Browse report at: https://www.psmarketresearch.com/market-analysis/utis-therapeutics-pipeline

Some of the key players involved in the development of UTIs therapeutics pipeline include Achaogen Inc., AmpliPhi Biosciences Corporation, and Iterum Therapeutics Limited.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Age-Related Macular Degeneration Therapeutic - Pipeline Analysis, Clinical Trials and Developments

The Age-related Macular Degeneration pipeline analysis report covers approximately 55 drug candidates in the pipeline in different stages of development.

Explore report sample at: https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-therapeutics-pipeline-analysis/report-sample

Many technologies are being developed that can bring the innovative treatment which can control the progression of Age-related macular degeneration. Some of these technologies include but are not limited to, HINGESCREEN technology platform, and CrossMab technology platform.

There are different novel molecule types that are present in the therapeutic pipeline of Age-related macular degeneration. Opregen is being developed by Cell Cure Neurosciences. Opregen is a stem cells molecule type useful in the treatment of Age-related macular degeneration.

Browse report at: https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-therapeutics-pipeline-analysis

Some of the key players developing drugs for Age-related macular degeneration include Formycon, AG, Allergan Plc, Hoffmann-La Roche, and others.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Europe Scar Treatment Market - Recent Study Including Growth Factors, Applications, Key Players and Forecasts till 2023

The Europe scar treatment market size was valued at $5.2 billion in 2016, which is expected to reach $9.8 billion by 2023, growing at a CAGR of 9.6% during the forecast period (2017-2023). Topical scar treatment is expected to witness highest growth during the forecast period in the European scar treatment market due to increasing disposable income, rising prevalence of chronic wounds and availability of different types of topical scar treatment products. Topical scar treatment is followed by surface scar treatment, laser scar treatment,  injectable scar treatment, invasive surgical scar treatment. Among the different types of scar, post-surgical scar was the most widely treated type of scar in Europe in 2016, followed by acne scar, keloid scar & hypertrophic scar, contracture scar, and stretch mark. The contribution of hospital in the European scar treatment market was the highest in 2016 mainly due to continuously developing reimbursement structure in the region.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/europe-scar-treatment-market/report-sample

The key players in the European scar treatment market are coming up with scar treatment products with innovative technologies, especially with laser therapy approaches. For instance, in September 2015, Lumenis Ltd. Announced promising clinical data of its advanced laser platform, UltraPulse with SCAAR FX, at the 16th European Burns Association Congress, in Hannover, Germany. Laser scar therapy, especially fractional ablative laser resurfacing, has turned out to be a momentous advancement in scar treatment and management and has been increasingly adopted as a promising approach in the treatment of burns and scars.

Browse Full Report at: https://www.psmarketresearch.com/market-analysis/europe-scar-treatment-market

Some of the key players operating in the European scar treatment market include Merz GmbH & Company KGAA, Mölnlycke Health Care AB, Smith & Nephew Plc, Syneron Medical Ltd., Lumenis Ltd., L'oreal S.A, H&R Healthcare Ltd., Avita Medical, Arbonne International, and Laverana GmbH & Co.KG.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Cancer Tumor Profiling Analysis, Market Key Players, Segmentation and Forecast to 2023

The cancer tumor profiling market in terms of technology has been segmented into next generation sequencing (NGS), quantitative polymerase chain reaction (QPCR), immunohistochemistry (IHC), in-situ hybridization (ISH), and microarray, based on technology. NGS held the largest share in the cancer/tumor profiling industry, standing at 33.1%, in 2016. This leading position of NGS is mainly characterized by increased awareness about NGS products due to rising promotional activities for these products among the research laboratories and academic institutes. The NGS category is also expected to grow at the highest CAGR during the forecast period.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market/report-sample

The players in the market are developing different biomarkers based on what is to be detected in a patient. For instance, Caris Life Sciences, develops several biomarkers that are based on IHC, that detects the level of protein expression, translocations and fusions, ISH, amplifications, detects gene deletions, NGS, rapidly examines and more broadly detects DNA mutations, copy number variations and gene fusions across the genome, and fragment analysis, that detects changes in RNA or DNA to indicate the absence or presence of genetic marker. Due to this precise detection using biomarkers for the cancer-causing agent, there is an increase in the use of biomarkers for cancer profiling and thereby driving the growth of the cancer/tumor profiling market.

The key players in the cancer/tumor profiling market are collaborating with other firms to expand their market share. In September 2017, Indivumed, GmbH and Helomics Corp. entered into a partnership to analyze human cancer biospecimens and annotated clinical data from consenting patients around the world.

Explore Report at: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market

Some of the other key players operating in the cancer/tumor profiling market include Illumina, Inc., NeoGenomics Inc., Caris Life Sciences, Inc., Oxford Gene Technology, HTG Molecular Diagnostics, Inc., RiboMed Biotechnologies, Inc., QIAGEN N.V. and NanoString Technologies, Inc.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Protein Expression Market Trends, Size, Growth and Development Forecast to 2023

According to the study, the global protein expression market is likely to grow from $1.4 billion in 2016 to $3.0 billion by 2023. Major key players in the market are developing products with technically advanced features that are designed to produce high protein yield, maintaining a balance of speed and scalability, thereby enhancing its application in the drug development workflow.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/protein-expression-market/report-sample

Some of the recent advanced product launched by the major players in the market include Gibco ExpiCHO expression system, launched in 2015 by ThermFisher Scientific Inc., that offers an increase yield of over 100-fold, thereby enabling upto 3g/L of protein yield; in comparison to its previous CHO system. Therefore, technically advanced products are a major factor driving the growth of the market during the forecast period.

Geographically, North America has been the largest market for protein expression, with the U.S. being the larger contributor to the regional market, as compared to Canada. The dominant position of the North American market is mainly attributable to the rise in R&D infrastructure, increased aging population, rise in healthcare expenditure and increasing prevalence of chronic diseases in the region.

Explore Report at: https://www.psmarketresearch.com/market-analysis/protein-expression-market

Increasing number of acquisitions is a key trend observed in the protein expression market. The key players globally are acquiring segments and/or companies to increase their share in the global market. In January 2017, Bio-Rad Laboratories, Inc. (Bio-Rad) acquired RainDance Technologies, Inc. (RainDance). As per the terms of acquisition, RainDance Technologies, Inc. offered its droplet-based solutions to Bio-Rad Laboratories, Inc. and has extended its reach into next generation sequencing applications. Similarly, Takara Bio USA Holdings, Inc. (“TBUSH”) acquired Rubicon Genomics, Inc. (Rubicon) in January 2017, the acquisition was aimed at expanding the product portfolio in next generation sequencing sample preparation. TBUSH also completed its acquisition of WaferGen Bio-systems, Inc. (WaferGen) in March 2017.

Some of the other key players operating in this industry include Merck KGaA, Genscript Biotech Corporation, Agilent Technologies, Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., New England Biolabs Inc., and Lonza Group Ltd.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook